The presence of ETV6 deletions was investigated in 215 chilof t(5;12) 10 and was subsequently found to be fused to a dren with acute lymphoblastic leukemia (ALL) using the loss number of different partners as a result of various leukemia- region of deletion that did not include ETV6 was found near
t(12;21) had lost the non-translocated allele of ETV6. 6 These cated by the detection of intragenic deletions in three patients.
results contrast with those of other studies using Southern blot
Although deletion of ETV6 and t(12;21) were associated in most
analysis that reported a much lower frequency of ETV6
patients, in eight cases (six B lineage and two T-ALL) LOH was
deletions in patients with a t(12;21). 16, 17 Besides, while detected at the ETV6 locus without ETV6-AML1 hybrid RNA.
t(12;21) is specifically found in children with B lineage ALL,
FISH studies conducted in five of these eight patients con12p deletions have also been detected in patients with other firmed the absence of translocation involving ETV6. In such patients, the other allele of ETV6 could be disrupted by either types of malignancies 19 including T-ALL, 20 and it is unclear a small deletion, a point mutation, or an epigenetic modification whether or not ETV6 is the target of 12p deletions in all cases and it will be of interest to study the structure and expression or in a specific subset of patients. Indeed, a recent study of of the remaining allele of ETV6 in these cases. Alternatively, a LOH for 12p markers in childhood ALL suggested that ETV6
tumor suppressor gene located close to ETV6 and CDKN1B
might not be the target of all 12p deletions, since a second could be the target of deletions.
region of deletion that did not include ETV6 was found near
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CDKN1B
. 4 The aims of the present study were to establish the frequency of ETV6 deletions in a large series of children with B and T lineage ALL, to determine the occurence of small deletions involving specifically ETV6 that may incriminate this Introduction gene as the target gene of the deletions, and to correlate the presence of these deletions with the presence of t(12;21). We Abnormalities of the short arm of chromosome 12 are quite used four intragenic or juxtagenic microsatellite markers to common in various hematological malignancies including detect allelic deletions of ETV6, and the t(12;21) translocation acute myeloid leukemia, myelodysplastic syndrome, myelowas sought by FISH and/or RT-PCR of the ETV6-AML1 proliferative disease and acute lymphoblastic leukemia (ALL). 1 chimeric transcript. Chromosome 12p alterations consist of both deletions and translocations. Recent studies using microsatellite markers have shown that loss of heterozygosity (LOH) in the chromoPatients and methods somal region 12p12-13 is found in 20-40% of cases in childhood ALL. [2] [3] [4] This suggested that a tumor suppressor gene Patients (TSG) might be located in this region whose inactivation would participate in leukemogenesis. 5 LOH mapping and We studied 215 children (aged 3 months to 15 years) with FISH analysis indicated that, in the majority of patients, the ALL (183 B lineage ALL, 32 T-ALL). Eight of these children deletion contained two genes, the CDKN1B gene (previously were studied both at diagnosis and at marrow relapse. Chilnamed KIP1) and the ETS-variant gene 6 (ETV6, previously dren were consecutively diagnosed and unselected, except named TEL).
3,4,6-9 CDKN1B encodes the cyclin-dependent that inclusion required the presence of at least 70% of blasts kinase inhibitor p27 that is a regulator of the cell cycle and in marrow at the time of diagnosis or relapse (13 children therefore a candidate TSG, but several studies concluded that have been excluded because of a low percentage of blasts in the remaining allele of this gene is not mutated in patients marrow). ALL were classified on the basis of lymphoid morwith one deleted allele.
3,4 ETV6 was cloned at the breakpoint phologic appearance and immunophenotype as assessed by flow cytometry. ALL were defined as belonging to the T lineage based on the presence of at least two of the T cell anti- Preparation of mononuclear cell lysates cDNA using primers P-PBGD (5′-AGCGGAGCCATG-TCTGGTAACGGCAATG-3′)and N-PBGD (5′-AGGCCAGGGBone marrow (BM) was collected on EDTA before induction therapy and during clinical remission between 6 and 24 TACGAGGCTTTCAATGTTG-3′) under the same PCR conditions as described above but with an annealing extension months of therapy according to the EORTC 58 881 followup protocol. Mononuclear cells were separated by gradient temperature of 60°C.
Specificity of the amplification was tested by Southern blot centrifugation over Ficoll (Lymphoprep; Pharmacia, Uppsala, Sweden), washed in 0.9% NaCl, counted, and aliquots of cells hybridization to radio-labeled junctional probes for ETV6-AML1 (5′-AGAATAGCAGAATGCATACT-3′). Frequency of monoallelic ETV6 deletion in childhood ALL 2.5 mm MgCl 2 and 10 mm Tris-HCl (pH 7.5) and incubated for 2 h at 60°C in the presence of 1 mg/ml proteinase K. Volumes were adjusted to obtain 6 ng of DNA per l of lysate.
The presence of allelic deletions of ETV6 was investigated in 215 children with ALL using the LOH approach. Partial results After a 10-min incubation at 95°C, the lysates were stored at −20°C until analysis.
concerning 66 of these children (including 16 with LOH) have been previously reported. 6 The polymorphic markers used for this screening were D12S1697, D12S89, CA159A7 and D12S98. Markers D12S89 and CA159A7 are located within Search for loss of heterozygosity the ETV6 gene. D12S89 has been previously shown to map immediately upstream of exon 2 while CA159A7 maps in the Seven simple tandem repeat (STR) markers were used that span the chromosome bands 12p12-13. These markers are 5′ region of exon 1B. 21 D12S1697 is located 7 kb upstream of exon 1A of ETV6, and D12S98 is about 50 kb downstream ordered from telomere to centromere: D12S1697, D12S89, CA159A7, D12S98, D12S1581, D12S1580 and D12S320. 3, 21 of exon 8. 21 Percentages of LOH observed for each marker are reported Loss of heterozygosity was evidenced by comparison of allelic patterns of amplified DNA on the diagnosis sample in Table 1 . Among the 215 patients studied, 210 (98%) were informative for at least one intragenic marker of ETV6. (blasts) and on a remission sample (normal cells) from each patient. Microsatellite typing was achieved using PCR and a The rate of LOH was similar with all four markers, and a percentage of about 18% of LOH among informative cases fluorescent automated laser DNA sequencer, as previously described.
3 Primer sequences and percentage of heterozygosis detected when isolated markers are considered ( Table 1) . Compilation of the results obtained with the four markers ity were obtained from the Genome Data Base (Welch Medical Library, Johns Hopkins University, Baltimore, MD, USA).
allowed the detection of LOH for at least one marker in 50 out of 215 patients (23%). Although deletional events were detected in ALL from both lineages, the observed frequency was significantly higher in B lineage ALL (26%) than in T-ALL FISH (6%) ( 2 test significant at P Ͻ 0.01) ( Table 1 ). In eight patients (two patients with 12p alterations and six without 12p Probes used for in situ hybridization consisted of YAC958b8, Cos50F4 and whole chromosome painting probes for chromoalteration), results obtained at diagnosis and at marrow relapse were compared and no difference was observed. some 12 (Coatasome, Oncor; Dako, Trappes, France). These probes and FISH conditions were as previously decribed.
6,22
The presence of a t(12;21)(p13;q22) was studied in a total of 134 patients (125 B lineage ALL, nine T-ALL) including 42 cases with LOH. The study was conducted by RT-PCR alone (n = 68), FISH alone (n = 27) or both techniques (n = 39),
RT-PCR analysis depending on the material available. RNA was extracted from blasts and RT was carried out with 1 g of RNA using random priming as previously described. 23 One tenth of the reaction was submitted to PCR amplification Deletion of ETV6 in patients with a t(12; 21) with various combinations of primers: ETV6-AML1 was amplified using P-TEL (5′-GAAGAGCACGCCATGCCCATTGGGAThe t(12;21) was never detected in T-ALL but was detected in 44 patients with B lineage ALL (Table 2) . In one patient, RT-GAATA-3′ nucleotides 1000-1029) 10 and N-AML1 (5′-GCGGCGTGAAGCGGCGGCTCGTGCT-3′: complementary PCR yielded an ETV6-AML1 product shorter than the usual transcript that did not hybridize to the junctional probe. to nucleotides 700-724). 24 PCR were performed in 25 l reaction mixtures containing Sequencing of this fragment showed that it consists of a ETV6-AML1 transcript lacking the second AML1 exon (39 bp), poss-10 mm Tris-HCl (pH 9.0), 50 mm KCl, 2.5 mm MgCl 2 , 200 m of each dNTP, 10 pmoles of each primer, and 0.25 U of Taq ibly because of an alternative translocation breakpoint on AML1. Thirty-four patients (77%) for whom a t(12;21) was polymerase (Appligene, Strasbourg, France). After a 5-min denaturation step at 94°C, 40 cycles were performed as foldetected displayed LOH at the ETV6 locus. In 10 patients, no an unbalanced translocation of chromosome 12 (Figure 2) . In order to specify the extent of the 12p deletion in these patients, additional markers spanning the 12p12-13 chromodeletion of ETV6 was detected when studied with polymorsomal bands were tested (from telomere to centromere: phic markers (Table 2) . D12S77, D12S1581,D12S1580 and D12S320). Deleted areas Seven patients with a t(12;21) had a deletion with at least were large in most patients and included all or most of the one border lying within the ETV6 gene (Figure 1 ). Four of markers tested, which encompass CDKN1B (Figure 2 , patients these patients displayed LOH for a single marker, D12S89
8-10 and 12-15).
Discussion
The frequency of 12p deletion evidenced by cytogenetics is 5% in childhood ALL. 25, 26 In our series of unselected childhood ALL, LOH of ETV6 markers was found in 23% of cases (6% of T-ALL and 26% of B lineage ALL) confirming that this represents a major genetic alteration in childhood ALL, frequently missed by cytogenetic analysis. The frequence of LOH involving marker D12S89 is 19% among 180 informative cases in our series which is intermediate between the results of Stegmaier et al 3 and Takeuchi et al 4 who reported LOH frequencies of 14% (out of 63 patients) and 26% (out of 82 patients), respectively. The difference could result from a dif- patients aged 15 to 18. 2 The prevalence of LOH in B lineage ALL was much higher than in T-ALL. This is related to the deletions of ETV6 have been observed (Figure 1, patients 1 recently reported a case of ALL with a t(12;21) associated with patients (77%) for whom a t(12;21) was observed displayed LOH of the ETV6 markers. This underscores the frequency of a t(3;12) disrupting the other ETV6 allele. In this case, the t(3;12) may inactivate the second ETV6 allele and be funcdeletions associated with t(12;21) because three additional patients with t(12;21) had a deletion only in a subclone of tionally similar to deletions commonly observed in most of the patients with t(12;21). blasts (data not shown), a finding that has been previously decribed, 6,27 and because a small deletion or another inactivChromosomal translocations generally participate in the tumoral phenotype via the production of an oncogenic fusion ating event cannot be excluded. Some 12p deletions have been described that affect the der(12)t(12;21) chromosome protein or the overproduction of an oncogene. 29 Fusions proteins involving ETV6 that have been identified so far are and are likely to result from unbalanced translocations. 28 In our series, deletions always concerned the non-translocated believed to be oncogenic. The ETV6-PDGFR␤ fusion transcript resulting from t(5;12) was tested for transforming activity chromosome 12 homologue. This was either assessed directly by FISH or indirectly from the presence of a ETV6-AML1 tranin cultured mammalian cell lines. ETV6-PDGFR␤ confers factor-independent growth to the interleukin 3-dependent cell script in patients with LOH for ETV6 markers encompassing the translocation breakpoint.
line Ba/F3. 30 Identical results were obtained for ETV6-ABL.
30
Although there is no experimental demonstration of the The frequency of the association translocation/deletion reported here contrasts strikingly with reports from other oncogenic properties of ETV6-AML1, several lines of evidence argue for such a role. The translocation breakpoint is highly investigators. Evidence for deletion of the non-translocated allele of ETV6 was found in only seven out of the 35 patients conserved, ETV6-AML1 transcript is always present, in contrast with the reciprocal transcript which is only found in with t(12;21) (20%) studied by Shurtleff et al 17 and in two out of the eight patients (25%) studied by Romana et al. 16 Techniabout half of the cases, 6 and the ETV6-AML1 transcript leads to the production of a chimeric protein detectable by Western cal differences may partly account for this apparent discrepancy. For example, the presence of residual normal cells in blot (data not shown).
In addition to the production of the ETV6-AML1 fusion problastic samples makes it very difficult to assess the deletions using Southern blot. The use of an automated fluorescent tein, t(12;21) inactivates one allele of ETV6 and this may also be significant for the oncogenic process. The function of ETV6 sequencer to analyze PCR products permits an accurate determination of allelic ratios and enables a reliable detection of is still unknown. The member of the ETS family with the most homology to ETV6 is the drosophila gene YAN/POK, a tranallelic imbalance even in the presence of some normal cells. In addition, about 25% of ETV6 deletion involves only a part scriptional repressor inactivated by the ras1/MAPK signal. YAN/POK inactivation results in overproliferation of cells from of this gene. Small deletions might not have been covered by the probes these authors used for Southern blotting. different tissues. 31,32 ETV6 could act as a TSG, with t(12;21) disrupting one copy of ETV6 and the deletion being the When associated with a t(12;21), ETV6 is very likely to be the target of deletions as indicated by the detection of intrasecond inactivating event according to the Knudson hypothesis. 33 The generation by t(12;21) of a fusion protein likely to genic deletions in a number of our patients and the constant involvement of ETV6 in deletions. Moreover, non-overlapping be oncogenic is not in contradiction with the assumption that
